雪迪龍(002658.SZ):擬減持不超過1%已回購股份
格隆匯8月4日丨雪迪龍(002658.SZ)公佈,第五屆董事會第二十次會議,審議通過了《關於回購股份集中競價減持計劃的議案》,根據公司於2024年2月7日披露的《關於回購公司股份方案的公告》和《回購報告書》中的回購股份用途約定,同意公司以集中競價交易方式減持部分已回購股份,擬減持數量不超過6,357,609股,即不超過公司總股本1%,減持期間爲自本公告發布之日起15個交易日之後三個月內(即2025年8月27日至2025年11月27日,根據中國證監會及深圳證券交易所相關規定禁止減持的期間除外,下同),減持價格根據減持時的二級市場價格確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.